STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

Insider stock sales at Issuer (NASDAQ: CRWV) under 10b5-1 plans

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV filed a Form 144 notice covering a planned sale of 1,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $80,140.00 and an approximate sale date of 01/12/2026 on NASDAQ. These shares were acquired as founder shares on 02/25/2019 from the issuer.

The filing also lists extensive sales of the issuer’s common stock during the prior three months by the same holder and related trusts under Rule 10b5-1 trading plans. Transactions include multiple December 2025 and January 2026 sales in blocks such as 102,835-share tranches for several million dollars each, and a separate sale by a non-affiliate donee of 257,733 shares on 12/01/2025 for $19,592,527.61.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows ongoing insider-related sales via Rule 10b5-1 plans.

This Form 144 indicates an intention to sell 1,000 common shares of CRWV, valued at $80,140.00, with an expected sale date of 01/12/2026 on NASDAQ. The shares were originally acquired as founder shares on 02/25/2019, suggesting they are long-held insider equity rather than recent grants.

The document also details a pattern of sizeable sales over the prior three months by the same individual and multiple related trusts under Rule 10b5-1 plans. Individual tranches reach 102,835 shares with multimillion-dollar proceeds, and a non-affiliate donee sale of 257,733 shares generated $19,592,527.61 on 12/01/2025. These transactions reflect structured liquidity activity, but without float or ownership baselines in this excerpt, the overall impact on ownership concentration or market float cannot be inferred from these figures alone.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the CRWV Form 144 filing disclose?

The Form 144 discloses an intention to sell 1,000 shares of CRWV common stock, with an aggregate market value of $80,140.00, through Morgan Stanley Smith Barney on or about 01/12/2026 on NASDAQ.

How and when were the CRWV shares in this Form 144 acquired?

The 1,000 CRWV common shares covered by this notice were acquired as founder shares from the issuer on 02/25/2019, with payment made on the same date.

What prior CRWV stock sales are reported over the last three months?

The filing lists multiple CRWV common stock sales in December 2025 and January 2026 by the same holder and related trusts under Rule 10b5-1 plans, including blocks such as 102,835 shares sold on several dates and a 257,733-share sale by a non-affiliate donee on 12/01/2025 for $19,592,527.61.

Are the recent CRWV stock sales made under Rule 10b5-1 trading plans?

Yes. Many of the reported transactions are identified as 10b5-1 sales for various trusts and for Brannin J. McBee, indicating they are executed under pre-arranged Rule 10b5-1 trading instructions.

Which broker is handling the planned CRWV Form 144 sale?

The planned sale of 1,000 CRWV common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY 10004.

On which exchange will the CRWV shares covered by Form 144 be sold?

The Form 144 specifies that the 1,000 common shares are intended to be sold on the NASDAQ stock market.